AKKARAJU SRINIVAS bought MLYS
February 19, 2026 · Form 4 insider transaction
AKKARAJU SRINIVAS bought 8,300 shares of Mineralys Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,300
Price
$0.00
Total value
N/A
InsiderAKKARAJU SRINIVAS
RoleDirector, 10% owner
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2026
Filing dateFebruary 20, 2026
Shares owned after8,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests in 12 substantially equal monthly installments following the date of grant.